Add to ORKGThe above titled paper examined the Food and Drug Administration\u27s (FDA\u27s) warning letters and notice of violations (NOV) over a 10-year period. Findings from this content analysis reinforced what has been the primary issue for prescription direct-to-consumer advertising (DTCA) since its beginning, the fair balance of risk and benefit information. As opposed to another analysis in 2026 about this still being an issue, is there anything that can be done to prevent this problem from continuing
This Comment will explore whether Washington courts should recognize direct-to-consumer advertising ...
In 1997 the FDA reinterpreted its regulations such that major statements in advertisements could be ...
Hyosun Kim’s report “Trouble Spots in Online Direct to Consumer Prescription Drug Promotion: A conte...
The above titled paper examined the Food and Drug Administration’s (FDA’s) warning letters and notic...
The above titled paper examined the Food and Drug Administration’s (FDA’s) warning letters and notic...
Background For the purpose of understanding the Food and Drug Administration’s (FDA’s) concerns re...
In 2007, the pharmaceutical industry spent more than $4.9 billion on direct-to-consumer advertising ...
Kim’s overview of Food and Drug Administration (FDA) regulatory actions from 2005 to 2014 is a compr...
Background: For the purpose of understanding the Food and Drug Administration’s (FDA’s) concerns r...
The adoption and use of digital forms of direct-to-consumer advertising (also known as “eDTCA”) is o...
Kim’s overview of Food and Drug Administration (FDA) regulatory actions from 2005 to 2014 is a comp...
Thesis (M.P.P.A., Public Policy and Administration) -- California State University, Sacramento, 2010...
This commentary discusses pertinent issues from Hyosun Kim’s paper on online prescription drug promo...
Prescription medicines are now frequently promoted on television, a change that has prompted strong ...
Testimony issued by the Government Accountability Office with an abstract that begins "The Food and ...
This Comment will explore whether Washington courts should recognize direct-to-consumer advertising ...
In 1997 the FDA reinterpreted its regulations such that major statements in advertisements could be ...
Hyosun Kim’s report “Trouble Spots in Online Direct to Consumer Prescription Drug Promotion: A conte...
The above titled paper examined the Food and Drug Administration’s (FDA’s) warning letters and notic...
The above titled paper examined the Food and Drug Administration’s (FDA’s) warning letters and notic...
Background For the purpose of understanding the Food and Drug Administration’s (FDA’s) concerns re...
In 2007, the pharmaceutical industry spent more than $4.9 billion on direct-to-consumer advertising ...
Kim’s overview of Food and Drug Administration (FDA) regulatory actions from 2005 to 2014 is a compr...
Background: For the purpose of understanding the Food and Drug Administration’s (FDA’s) concerns r...
The adoption and use of digital forms of direct-to-consumer advertising (also known as “eDTCA”) is o...
Kim’s overview of Food and Drug Administration (FDA) regulatory actions from 2005 to 2014 is a comp...
Thesis (M.P.P.A., Public Policy and Administration) -- California State University, Sacramento, 2010...
This commentary discusses pertinent issues from Hyosun Kim’s paper on online prescription drug promo...
Prescription medicines are now frequently promoted on television, a change that has prompted strong ...
Testimony issued by the Government Accountability Office with an abstract that begins "The Food and ...
This Comment will explore whether Washington courts should recognize direct-to-consumer advertising ...
In 1997 the FDA reinterpreted its regulations such that major statements in advertisements could be ...
Hyosun Kim’s report “Trouble Spots in Online Direct to Consumer Prescription Drug Promotion: A conte...